MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Monoamine loss and depression in Parkinson’s disease: a PET study

BL. Xu, XL. Liu, SY. Liu, O. Barret, G. Tamagnan, H. Qiao, TB. Song, J. Lu, P. Chan (Beijing, China)

Meeting: 2023 International Congress

Abstract Number: 1638

Keywords: Depression

Category: Parkinson's Disease: Neuroimaging

Objective: 1)To evaluate the imaging manifestations of monoamine changes in PD patients with depression through 18F-FP-DTBZ PET; 2) To explore the relationship between monoamine changes and quality of life in PD

Background: Depression was one of the most common non-motor symptoms of Parkinson’s disease (PD). Dopamine, serotonin and noradrenaline system in the brain had been proven separately to be associated with depression in PD patients, while the association between total monoamine and depression was not studied. The use of monoamine-B inhibitor was linked with better resilience and mode

Method: This study included twenty six PD participants and eighteen healthy participants. According to the discriminating threshold score of HAMD-24 for depression, PD patients scored > 7 points were categorized into depressed PD (dPD) group, and others in the non-depressed PD group. After injection of 222 MBq 18F-FP-DTBZ intravenously and a 90-min quiet rest, a single frame PET(hybrid 3.0-T PET/MR) scan was acquired

Results: dPD patients showed significantly higher scores in HAMD-24 (P<0.001), HAMA (P<0.001), RBDQ-HK (P=0.045) and PDQ-39 (P=0.018) comparing to the PD group. The decrease of SUVRs values was significantly more severe in dPD than that of PD in ADP, AVP and NAc regions(*P = 0.032,*P = 0.004, *P= 0.002).HAMA score was negatively correlated with SUVRs values in ADP, AVP, PVP and NAc (P=0.031, r=-0.423; P=0.004, r=-0.551; P=0.02, r=-0.455; P=0.002, r=-0.570) ; while HAMD-24 score was negatively correlated with the values of SUVRs in AVP and NAc (P=0.01, r=-0.497; P=0.008, r=-0.508). The daily life quality of PD patients showed by PDQ-39 scores was negatively correlated with the SUVRs values in Snigra, ADP, AVP, PDP and PVP regions (P=0.014, r=-0.497; P=0.011, r=-0.512; P=0.008, r=-0.529; P=0.007, r=-0.534; P=0.007, r=-0.534)

Conclusion: The quality of life and symptoms of RBD were worse in PD patients with depression .Depression, anxiety and PDQ39 were negatively correlated with monoaminergic disruption in limbic and associative striatum subregions . Depression was also negatively correlated with monoamine loss in the NAc region despite similar severity of motor symptoms between the two groups. The results suggested that the monoamine level as a whole in the brain of PD patients may be critical for the daily management of PD.

To cite this abstract in AMA style:

BL. Xu, XL. Liu, SY. Liu, O. Barret, G. Tamagnan, H. Qiao, TB. Song, J. Lu, P. Chan. Monoamine loss and depression in Parkinson’s disease: a PET study [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/monoamine-loss-and-depression-in-parkinsons-disease-a-pet-study/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/monoamine-loss-and-depression-in-parkinsons-disease-a-pet-study/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley